Back

The future of oral anticoagulation

29 August 2017 (15:12 - 15:30)
Organised by:
Congress Presentation Part of: How to make oral anticoagulation safe Drug therapy ESC Premium Access ESC Congress 2017

About the speaker

Photo
Doctor Jeffrey Weitz

Thrombosis & Atherosclerosis Research Institute (TaARI), Hamilton (Canada)

4 More presentations in this session

Presentation thumbnail
State of the Art: oral anticoagulation in the challenging patient
Professor P. Kirchhof (Hamburg, DE)
Slides Video
Presentation thumbnail
Use of aspirin and impact of quality of anticoagulation control on outcomes in patients with atrial fibrillation: an analysis from the SPORTIF trials
Doctor M. Proietti (Milan, IT)
Abstract Slides Video
Presentation thumbnail
Increased bleeding events in patients co-administered rivaroxaban and either cyp3A4 or p-gp inhibitors
Doctor J. Michel (Austin, US)
Abstract Slides Video
Presentation thumbnail
Clinical determinants of time in therapeutic range and the role of SAMe-TT2R2 score in atrial fibrillation patients receiving oral anticoagulation: data from FANTASIIA registry.
Doctor M. Esteve Pastor (Murcia, ES)
Abstract Slides Video

Access the full session

Session thumbnail
How to make oral anticoagulation safe

The Event

Event poster

ESC Congress 2017

29 August 2017 15:12 CET
You may be interested in
thumbnail
Congress Session
How can targeting FXI(a) advance antithrombotic therapy for stroke prevention?
27 August 2023
thumbnail
Congress Presentation
Oral anticoagulation in 13,344 adult patients with congenital heart disease (ACHD) in a longitudinal real-world setting in 2005-2017
2 September 2019
thumbnail
Webinar
How to improve patient compliance necessitating oral anticoagulation due to nonvalvular atrial fibrillation
18 November 2021
thumbnail
Congress Presentation
Patients' perspective on a pill-in-the-pocket oral anticoagulation as an alternative stroke prevention strategy in atrial fibrillation
4 April 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources